Reflections on Medical Oncology: 25 Years of Clinical Trials—Where Have We Come and Where Are We Going?
- 1 January 2008
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (1), 6-8
- https://doi.org/10.1200/jco.2007.13.8156
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Statistical Power of Negative Randomized Controlled Trials Presented at American Society for Clinical Oncology Annual MeetingsJournal of Clinical Oncology, 2007
- Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Association between pharmaceutical involvement and outcomes in breast cancer clinical trialsCancer, 2007
- Quality of Randomized Controlled Trials Reporting in the Primary Treatment of Brain TumorsJournal of Clinical Oncology, 2006
- Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized TrialsJournal of Clinical Oncology, 2005
- Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate CancerNew England Journal of Medicine, 2004
- Quality of Abstracts Describing Randomized Trials in the Proceedings of American Society of Clinical Oncology Meetings: Guidelines for Improved ReportingJournal of Clinical Oncology, 2004
- Factors Associated With Failure to Publish Large Randomized Trials Presented at an Oncology MeetingJAMA, 2003
- Trends in Clinical Trials Reports in Common Cancers Between 1989 and 2000Journal of Clinical Oncology, 2003
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996